Drug Markets/Raloxifene

Raloxifene

4 NDCs across 2 manufacturers|4 Generic,0 Brand

Raloxifene is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Raloxifene is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $0.22 to $0.22 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

2

competing in market

Price Spread

$0.22 – $0.22

per EA

7d Activity

4↓0 flat

avg -5.3% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing RALOXIFENE

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Raloxifene used to treat?

Raloxifene is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.

How many Raloxifene products are on the market?

The Raloxifene drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.

What is the price range for Raloxifene?

NADAC reference prices for Raloxifene range from $0.2235 to $0.2235 per EA.

Which manufacturers make Raloxifene?

2 manufacturers list Raloxifene in NADAC. Ranked by number of NDCs, the largest are Cipla USA Inc. (3), American Health Packaging (1).

How has the price of Raloxifene changed recently?

Over the past 7 days, 0 Raloxifene NDCs rose and 4 fell, with a market-wide average change of -5.3%.